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Abstract
The V protein of SV41 targets STAT1, while a specific loss of STAT2 is induced by the hPIV2 V protein. We established HeLa cells
constitutively expressing various chimeric proteins between the hPIV2 and SV41 V proteins, and which STAT (STAT1 or 2) was expressed
in these cells was analyzed. Both the P-V common domain and the V specific domain of hPIV2 V protein are necessary for STAT2 lowering.
The internal domain (aa145–173) containing a large number of nonidentical amino acids between hPIV2 and SV41 does not direct STAT
tropism, and the regions necessary for STAT2 lowering are discontinuous. The N-terminal domain (aa1–104) and the internal domain
(aa126–196) of the hPIV2 V protein do not determine STAT tropism. HeLa cells expressing A105E or H108P show distinct expression of
STAT2, but do show low expression or a loss of STAT1, indicating that the amino acid residues 105 and 108 of the hPIV2 V protein are
essential for STAT2 lowering. Interestingly, there is an important amino acid(s) in the region (aa121–125) for STAT2 lowering, and the
presence of either amino acid residue 123 or 125 of the hPIV2 V protein is necessary for lowering of STAT2. In addition, HeLa cells
expressing S216D or 1217R expressed STAT2, but no STAT1, indicating that the amino acid residues 216 and 217 of the hPIV2 V protein
are indispensable for STAT2 lowering. HeLa/hPIV2V cells and HeLa/S104/P are resistant to IFN-, while they are sensitive to IFN-. On
the other hand, HeLa/SV41V, HeLa/S216D, and HeLa1217R cells are resistant to both IFNs. Intriguingly, HeLa/A105E and HeLa/H108P
cells were found to be sensitive to IFN-.
© 2003 Elsevier Inc. All rights reserved.
Introduction
Interferons (IFNs) modulate a number of biological func-
tions, namely, virus replication, immune response, cell
growth, and differentiation. Recently, IFN-mediated cell
signaling has been intensively investigated. Binding of IFN
to the cell surface receptor initiates activation of the recep-
tor-associated tyrosine kinases, Jak1 and Tyk2 (IFN-/),
or Jak1 and Jak2 (IFN-) (Stark et al., 1998; Samuel, 1991).
IFN- acts through STAT1/STAT1 homodimer binding
to the gamma activating sequence (GAS) and IFN-/ acts
through STAT1/STAT2/p48 binding to the IFN-stimulated
response element (ISRE) (Stark et al., 1998; Samuel, 1991).
The C protein of respirovirus and the V protein of rubu-
lavirus have recently been reported to be responsible for the
virus-mediated inhibition of IFN signaling (Garcin et al.,
1999; Didcock et al., 1999b; Gotoh et al., 1999). Many
investigators have recently focused their attention on the
molecular mechanisms involved in the anti-IFN effect me-
diated by paramyxovirus (Yokosawa et al., 1998; Garcin et
al., 1999; Didcock et al., 1999a,b; Gotoh et al., 1999; Kom-
atsu et al., 2000; Young et al., 2000; Nishio et al., 2001).
Sendai virus, hPIV-3, SV5, and mumps virus have been
found to block both type I and type II IFN signaling,
whereas hPIV2 blocks type I IFN signaling (Young et al.,
2000; Nishio et al., 2001). There is a specific reduction in
the level of serine 727-phosphorylated form of STAT1 in
Sendai virus- and hPIV-3-infected cells (Young et al.,
2000). Among rubulaviruses, there is a notable variation in
how they interfere with IFN action. Whereas SV5 and MuV
all act by lowering STAT1, hPIV2 acts by lowering STAT2
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(Yokosawa et al., 1998; Didcock et al., 1999a,b; Young et
al., 2000; Nishio et al., 2001). Furthermore, STAT1 is not
detectable in SV5 V-expressing cells, and the cells fail to
signal in response to either / IFNs or IFN- (Didcock et
al., 1999b). In contrast, STAT2 is absent from hPIV2 V-
expressing cells, and IFN-/, but not IFN-, signaling is
blocked in these cells (Young et al., 2000; Nishio et al.,
2001; Parisien et al., 2001). It has recently been reported
that the V proteins of SV5, Sendai virus, and hPIV2 inhibit
induction of IFN-.
Though the V protein of SV41 shows high amino acid
sequence identity with hPIV2 (69.3%) (Kawano et al.,
1993), their STAT tropism is different from each other, that
is, STAT1 cannot be detected in HeLa cells expressing
SV41 V protein, while HeLa cells expressing hPIV2 V
protein express no STAT2 (Nishio et al., 2000). In this
study, we determined amino acids of the hPIV2 V protein
that are responsible for lowering STAT2 by using the chi-
meric/mutant V proteins between hPIV2 and SV41.
Results
Both the P-V common domain and the V specific domain
of hPIV2 are necessary for STAT 2 lowering
First, two chimeric V proteins were created, that is, (1)
the N-terminal 164 amino acids (P-V common domain) of
hPIV2 V protein were replaced with the corresponding
N-terminal 164 amino acids of SV41 V protein (S164/P),
and (2) the C-terminal 61 amino acids (cysteine-rich V
specific domain) of hPIV2 V protein were replaced with the
corresponding C-terminal 61 amino acids of SV41 V pro-
tein (P164/S) (Fig. 1A). We established HeLa cells consti-
tutively expressing each chimeric protein, designated HeLa/
S164/P and HeLa/P164/S cells, and then examined which
STAT (STAT1 or 2) was expressed in these cells. Expres-
sion of hPIV2 V or SV41 V protein led to a loss of cellular
STAT2 or STAT1, respectively. Unexpectedly, defect of
STAT1 was found, but expression of STAT2 was clearly
detected, in both HeLa/S164/P and HeLa/P164/S cells (Fig.
2A), indicating that both the P-V common domain and the
V specific domain of hPIV2 V protein are necessary for
STAT 2 lowering.
Regions necessary for STAT 2 lowering are discontinuous
Since the internal domain (aa145–173) contains a large
number of nonidentical amino acids between hPIV2 and
SV41 V proteins, we constructed two chimeric V proteins
(S144/P173/S and P144/S173/P) in which the internal do-
main of each was replaced with that of the other (Fig. 1A).
Furthermore, two chimeric V proteins were created as fol-
lows: one from replacement of the C-terminal 52 amino
acids of hPIV2 V protein with the corresponding region of
SV41 V protein (P173/S), and the other one from replace-
ment of the N-terminal 144 amino acids of hPIV2 V protein
with the corresponding region of SV41 V protein (S144/P)
(Fig. 1A). HeLa cells expressing either P173/S or S144/P
showed defect of STAT1. Interestingly, expression of S144/
P173/S or P144/S173/P led to a loss of cellular STAT1 or
STAT2, respectively (Fig. 2B). These findings indicate that
this internal domain (aa145–aa173) does not direct STAT
tropism and the regions necessary for STAT 2 lowering are
discontinuous.
The amino acid(s) in the region (aa105–110) is important
for STAT 2 lowering
Subsequently, the N-terminal region of hPIV2 V protein
was sequentially replaced with the corresponding region of
SV41 V protein, and HeLa cells constitutively expressing
each chimeric V protein were established (Fig. 1B). As
shown in Fig. 3A, no or very low expression of STAT2 was
detected in HeLa cells expressing S58/P, S76/P, S79/P,
S87/P, S90/P, S93/P, S98/P, or S104/P, while distinct ex-
pression of STAT1 was found in these cells. On the con-
trary, HeLa cells expressing S110/P, S144/P, or S156/P
showed very low expression of STAT1, while expression of
STAT2 was clearly detected. These findings show that the
N-terminal domain (aa1–104) of the hPIV2 V protein does
not determine STAT tropism, and there is an important
amino acid(s) in the region (aa105–110) for STAT 2 low-
ering. Three nonidentical amino acids, aa105, aa108, and
aa110, between the hPIV2 and SV41 V proteins are found
in this region. Intriguingly, a faint band of STAT2 was
detected in HeLa cells expressing S93/P, S98/P, or S104/P
by using ECL (Fig. 3A).
The amino acid(s) in the region (aa121–125) is important
for STAT 2 lowering
As described above, expression of P144/S173/P led to a
loss of cellular STAT2. Consequently, the SV41-specific
region was sequentially extended from aa145 toward the
N-terminal (Fig. 1C). HeLa cells expressing P125/S173/P
showed defect of STAT2 and low expression of STAT1.
However, expression of other chimeric protein (P121/
S173/P, P117/S173/P, P110/S173/P, P93/S173/P, P90/
S173/P, P89/S173/P, P87/S173/P, or P69/S173/P) led to
distinct expression of STAT2, though STAT1 was scarcely
found (Fig. 3B), showing that the internal domain (aa126–
173) of the hPIV2 V protein does not direct STAT tropism,
and there is an important amino acid(s) in the region
(aa121–125) for STAT 2 lowering. Two nonidentical amino
acids between the hPIV2 and SV41 V proteins, aa123 and
aa125, are found in this region.
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Fig. 1. A diagram of the chimeric proteins. Blue lines represent the hPIV2 V specific amino acids and red lines represent the SV41 V specific amino acids,
while white boxes indicate common amino acids between the hPIV2 V and the SV41 V proteins. Numbers correspond to the amino acid positions of the V
protein.
Both aa105 and aa108 of the hPIV2 V protein are
essential for STAT 2 lowering
As described above, the region (aa105–125) was found
to be important for STAT 2 lowering. Thus, recombinant
plasmids encoding mutant V proteins of hPIV2, designated
A105E, H108P, K110R, I114/116L, V117A, N120T,
I121V, E123Q, and S125T, were constructed by site-di-
rected mutagenesis so that each one/two of 10 amino acids
in the hPIV2 V protein was replaced with its SV41 V
counterpart(s) (Fig. 1D). Since STAT2 could be clearly
detected in HeLa cells expressing A105E or H108P (Fig.
4A, B, and C), the amino acid residues 105 and 108 of the
hPIV2 V protein are essential for STAT 2 lowering. HeLa
cells expressing K110R, I114/116L, V117A, N120T, or
I121V showed no or low expression of STAT2 (Fig. 4A and
C). Interestingly, though there is an important amino acid(s)
in the region (aa121–125) for STAT 2 lowering, expression
of E123Q or S125T led to a loss of cellular STAT2, indi-
cating that the presence of either amino acid residue 123 or
125 of the hPIV2 V protein is necessary for STAT2 low-
ering. It is noteworthy that HeLa cells expressing A105E or
Fig. 2. Expression of STAT1, STAT2, and V protein in HeLa cells stably
expressing the hPIV2 V, SV 41 V, or the chimeric V protein. The lysates
of various cells were analyzed by SDS-PAGE (13%), and then electro-
phoretic transfer from gels onto PVDF transfer membranes was done.
Specific proteins were detected by Western blotting using mAbs against
STAT1, STAT2, or the V protein. (A) Untransfected HeLa cells HeLa/
hPIV2 V, HeLa/SV41 V, HeLa/S164/P [the N-terminal 164 amino acids
(P-V common domain) of hPIV2 V protein is replaced with the corre-
sponding N-terminal 164 amino acids of SV41 V protein], and HeLa/
P164/S [the C-terminal 61 amino acids (cysteine-rich V specific domain) of
hPIV2 V protein is replaced with the corresponding C-terminal 61 amino
acids of SV41 V protein] were analyzed. (B) We constructed four chimeric
V proteins (P173/S, S144/P, S144/P173/S, and P144/S173/P) and HeLa
cells constitutively expressing each chimeric V protein were established.
Fig. 3. Expression of STAT1, STAT2, and V protein in HeLa cells stably
expressing the chimeric V protein. The lysates of various cells were
analyzed by SDS-PAGE (13%), and then electrophoretic transfer from gels
onto PVDF transfer membranes was done. Specific proteins were detected
by Western blotting using mAbs against STAT1, STAT2, or the V protein.
(A) The N-terminal region of hPIV2 V protein was sequentially replaced
with the corresponding region of SV41 V protein, and HeLa cells consti-
tutively expressing each chimeric V protein were established. (B) SV41 V
specific region was sequentially extended from aa145 toward the N-termi-
nus of hPIV2 V protein. (C) Results using some independent cloned cells
expressing S104/P or P125/S173/P are shown. Mock shows vector trans-
fected HeLa cells.
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H108P showed expression of STAT2 that, though distinct,
was lower than did untransfected HeLa cells (Fig. 4A, B,
and C). A faint band of STAT1 was found in HeLa/A105E
cells (Fig. 4B).
The C-terminal amino acid of the hPIV2 V protein can be
replaced with that of the SV41 V protein for STAT 2
lowering
In the next experiment, the C-terminal region of hPIV2 V
protein was sequentially replaced with the corresponding
region of SV41 V protein, and HeLa cells constitutively
expressing these chimeric V proteins were established (Fig.
1E). The C-terminal amino acid (aa225) of the hPIV2 V
protein can be replaced with that of the SV41 V protein for
STAT 2 lowering, and further replacement with the SV41 V
protein led to distinct expression of STAT2 and a loss of
STAT1 (Fig. 4D).
Both aa216 and aa217 of the hPIV-2 V protein are
essential for STAT 2 lowering
As described above (Fig. 2B), expression of P144/
S173/P led to a loss of cellular STAT2. In addition, expres-
sion of P144/S190/P, hPIV-2 (R196T), or P196/S213/P
showed defect of STAT2, indicating that aa145–196 is not
related to STAT tropism (Figs. 1F and 4E). Consequently,
recombinant plasmids encoding mutant V proteins of
hPIV2, designated S216D, I217R, and H225N (described
previously), were constructed by site-directed mutagenesis
so that each one of three amino acids in the hPIV2 V protein
was replaced with its SV41 V counterpart (Fig. 1F). HeLa
Fig. 4. Expression of STAT1, STAT2, and V protein in HeLa cells stably expressing the chimeric/mutated V protein. The lysates of various cells were
analyzed by SDS-PAGE (13%), and then electrophoretic transfer from gels onto PVDF transfer membranes was done. Specific proteins were detected by
Western blotting using mAbs against STAT1, STAT2, or the V protein. (A) Recombinant plasmids encoding mutant V proteins of hPIV2 designated A105E,
H108P, K110R, I114/116L, V117A, N120T, I121V, E123Q, and S125T were constructed by site-directed mutagenesis, and HeLa cells constitutively
expressing these chimeric V proteins were established. (B) Results using eight independent cloned cells expressing A105E are shown. Mock shows vector
transfected HeLa cells. (C) Results using some independent cloned cells expressing H108P or K110R are shown. Mock shows vector transfected HeLa cells.
(D) The C-terminal region of hPIV2 V protein was sequentially replaced with the corresponding region of SV41 V protein, and HeLa cells constitutively
expressing these chimeric V proteins were established. (E) Recombinant plasmids encoding mutant V proteins of hPIV2, designated R196T, S216D, I217R,
and H225N, were constructed by site-directed mutagenesis, and three chimeric proteins (P144/S173/P, P144/S190/P, and P196/S213/P) were also constructed.
Subsequently, HeLa cells constitutively expressing these chimeric/mutant V proteins were established.
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cells expressing S216D or I217R showed a loss of STAT1,
while these cells distinctly expressed STAT2 (Fig. 4E).
These findings indicate that the amino acid residues 216 and
217 of the hPIV2 V protein are indispensable for STAT 2
lowering.
Intracellular localization of V protein and expression of
STAT1 in HeLa cells stably expressing chimeric/mutated
V protein of hPIV2
To determine intracellular localization of the chimer-
ic/mutant V proteins, untransfected HeLa, HeLa/S104/P,
HeLa/A105E, HeLa/H108P, HeLa/S216D, HeLaI217R
HeLa/hPIV2V, and HeLa/SV41V were fixed, immuno-
stained with mAbs specific for hPIV-2 V protein, and
then were observed with an immunofluorescence micro-
scope. The chimeric/mutant V proteins were also pre-
dominantly detected in the nuclei (Fig. 5A). Conse-
quently, STAT1 expression was analyzed by using
FACScan. As shown in Fig. 5B, HeLa/PIV-2V cells show
expression of STAT1 as much as untransfected HeLa
cells, while no STAT1 expression is found in HeLa/
SV41V, HeLa/S216D, and HeLa/I217R cells (Fig. 5A
and data not shown). HeLa/A105A and HeLa/H108P
cells showed no or lower expression level of STAT1 than
untransfected HeLa cells.
IFN sensitivity of HeLa cells expressing S104/P, A105E,
H108P, S216D, or I217R
Subsequently, we analyzed the biological activity of the
chimeras with respect to IFN signaling inhibition. The cells
were treated with 10 or 100 units of IFN- or IFN- for
24 h, and were then infected with Sindbis virus. As shown
in Table 1, HeLa/hPIV2V cells and HeLa/S104/P are resis-
tant to IFN-, while they are sensitive to IFN-. On the
other hand, HeLa/SV41V, HeLa/S216D, and HeLaI217R
cells are resistant to both IFNs. Intriguingly, HeLa/A105E
and HeLa/H108P cells were found to be sensitive to IFN-
(Table 1).
Discussion
Viruses of the Paramyxovirinae, similar to other viruses,
have evolved specific proteins that interdict IFN action as
part of a general strategy to counteract host innate immu-
nity. In many cases, this interdiction is accompanied by a
lowering of the intracellular levels of the STAT proteins
(Didcock et al., 1999b; Nishio et al., 2001; Pariesin et al.,
2001). Protein-protein interaction analysis indicates that the
V proteins of mumps virus, hPIV2, and SV5 interact phys-
ically with various STAT proteins, even with STAT3, in
vitro and in vivo (Nishio et al., 2002). The V/STAT com-
Fig. 5. (A) Expression and intracellular localization of V protein in HeLa cells stably expressing chimeric/mutated V protein of hPIV2. Untransfected HeLa
cells (1), HeLa cells expressing S104/P (2), A105E (3), H108P (4), S216D (5), I217R (6), hPIV2 V (7), and SV41 V (8) were fixed, immunostained with
mAbs specific for the hPIV-2 V, and then were observed with an immunofluorescence microscope. (B) Expression of STAT1 in HeLa cells stably expressing
chimeric V protein of hPIV2. Various cells were incubated with control or anti-STAT1 mAb, and then FITC-conjugated secondary antibody. Subsequently,
these cells were analyzed on a FACScan (Becton Dickinson) using Consort 30 software (Becton Dickinson). (—), control mAb; (—), anti-STAT1 mAb.
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plex formation requires a specific carboxyl segment of the V
protein, in which a tryptophan-rich motif that vaguely re-
sembles WW protein/protein interaction domain exists
(Nishio et al., 2002). This tryptophan-rich motif appears to
be required for V/STAT complex formation (Nishio et al.,
2002). This would not conflict with previous experiment
data that the IFN resistance determinant would map to the
cysteine-rich V specific domain (Kawano et al., 2001;
Nishio et al., 2001; Kubota et al., 2001; He et al., 2002). The
specific degradation of these STAT proteins is not deter-
mined by complex formation, but presumably at some later
stage of the degradation pathway. On the other hand,
V/STAT complex formation in vitro does not appear to
require an intact Zn2 binding cysteine cluster (Nishio et
al., 2002).
It has recently been shown that the V proteins of SV5,
hPIV2, and measles virus bind to the DDB1 [the 127-kDa
subunit of the UV damage specific DNA binding protein
(DDB)] (Lin, et al., 1998; Andrejeva et al., 2002; Ulane and
Horvath, 2002). The interaction of V protein with DDB1
involves the carboxyl-terminal domain of the V protein, and
either deletion of the V carboxyl-terminal domain or sub-
Fig. 5 (continued)
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stitution of the cysteine residues in the zinc binding domain
with alanine is able to disrupt DDB/V/STATs complex
formation, indicating that an intact Zn2 binding cysteine
cluster is required for binding of the V protein with DDB
(Andrejeva et al., 2002). We incidentally constructed a
mutant hPIV2 V protein, a new mutated V protein S216D/
C218R, in which serine 216 and cysteine 218 were replaced
with aspartic acid and argianine, respectively. Intriguingly,
lowering of STAT1 and STAT2 was not found in HeLa
cells expressing S216D/C218R (unpublished data). This
finding shows that cysteine residues are intrinsically related
to STAT lowering, though V/STAT complex formation
does not require an intact Zn2 binding cysteine cluster.
Recently it has been clarified that DDB1 plays a central
role in the degradation process of STATs (Andrejeva et al.,
2002; Ulane and Horvath, 2002). The V protein of an SV5
mutant that fails to target STAT1 for degradation does not
bind DDB1, and mutations in the N and C termini of V
protein that prevent the binding of V to DDB1 also prevent
V protein from blocking IFN signaling (Andrejeva et al.,
2002). In addition, treatment of HeLa/SV5-V cells, which
constitutively express the V protein of SV5 and thus lack
STAT1, with short interfering RNAs specific for DDB1,
results in a reduction in DDB1 levels with a concomitant
increase in STAT1 levels and a restoration of IFN signaling
(Andrejeva et al., 2002). These results suggest that DDB1,
STAT1, STAT2, and V protein may form part of a large
multiprotein complex that leads to the targeted degradation
of STAT1 by the proteasome (Andrejeva et al., 2002; Ulane
and Horvath, 2002).
To obtain a tool to reveal how selective lowering of
STAT by rubulavirus V protein occur, we needed to define
a minimal mutation of hPIV2 V protein that eliminates
STAT2 lowering activity. We used hPIV2-SV41 V protein
chimeras to define progressively smaller protein regions in
the hPIV2 V required for lowering STAT2. First, to deter-
mine a minimum region in the P-V common domain for
lowering STAT2, we established and analyzed HeLa cells
expressing S/P type chimera proteins. Low expression of
STAT2 and distinct expression of STAT1 was detected in
HeLa cells expressing S104/P, while HeLa cells expressing
S110/P showed very low expression of STAT1 and distinct
expression of STAT2. Consequently, we analyzed HeLa
cells expressing P/S/P type chimera proteins, and found that
P125/S173/P showed lowering of STAT2 and that expres-
sion of P125/S173/P.P69/S173/P led to distinct expression
of STAT2 and a loss or lowering of cellular STAT1. These
findings show that the N-terminal domain (aa1–104) and the
internal domain (aa126–173) of the hPIV2 V protein do not
determine for STAT tropism and that the regions necessary
for STAT 2 lowering are discontinuous. Thus, we focused
on hPIV2 V protein residues 105–125, since there could be
important amino acid(s) for STAT 2 lowering in regions
aa105–110 and aa121–125. Experimentation using point
mutated hPIV2 V protein designated A105I, H108P,
K110R, I114/116L, V117A, N120T, I121V, E123Q, and
S125T indicated that Alanine105 and Histidine108 were each
essential for lowering STAT2. However, expression of
E123Q or S125T led to a loss of cellular STAT2, indicating
that the presence of either amino acid residue 123 or 125 of
the hPIV2 V protein is necessary for STAT2 lowering, and
these amino acid residues compensate each other for their
ability to lower STAT2. Furthermore, in the C-terminal
region of hPIV2 V protein, Serine216 and Isoleucine217 of
the hPIV2 V protein were found to be essential for STAT2
lowering. Taken together, four amino acid residues, Ala-
nine105, Histidine108, Serine216, and Isoleucine217, of the
hPIV2 V protein were found to be essential for STAT2
lowering. Alanine105 and Histidine108 are located in the
internal P-V common domain of the hPIV2 V protein, while
Serine216 and Isoleucine217 are in the C-terminal V specific
domain of the hPIV2 V protein. Thus, the former amino
acid residues may be quite close to the latter amino acid
residues in three-dimentional structure. Alanine105 and His-
tidine108 are located close to Asparagine99 and Leucine101,
which are important amino acids in SV5 for blocking IFN
Table 1
Interferon susceptibility of HeLa cells expressing chimeric/mutant V
proteins
Cell Plaque numbers [reduction in plaques (%)]a
Interferon treatment
 
Species of interferon
IFN-
(100 units)
IFN-
(10 units) (100 units)
Untrasfected
HeLa
85 0 (100) 0 (100)b 0 (100)
HeLa/PIV2 V
clone 1
29 31 (1) 0 (100) 0 (100)
HeLa/SV41 V
clone 1
75.5 115 (1) 78 (1)
HeLa/S104/P
clone 1 109 107 (2) 0 (100)
clone 3 118.5 95 (20) 0 (100)
HeLa/A105E
clone 5 35.5 37 (1) 0 (100) 0 (100)
clone 6 234.5 282.5 (1) 54.5c (77) 21.5c (91)
clone 11 156.5 165 (1) 0 (100) 0 (100)
HeLa/H108P
clone 3 231.5 241 (1) 10.5c (95) 4c (98)
clone 4 256.5 255 (1) 0 (100) 0 (100)
clone 5 240 256 (1) 54.5c (73) 7c (93)
HeLa/S216D
clone 3
40.5 38.5 (5) 38 (6)
HeLa/I217R
clone 4
76 92.5 (1) 70 (8)
a Confluent monolayers of various cells were inoculated with 10 or 100
units of interferon- or interferon- and after incubation for 24 h, these
cells were infected with Sindbis virus. After 2 days of further incubation,
plaque numbers were counted.
b Shows full susceptibility to interferon.
c Plaque size is very small compared with that in untransfected HeLa
cells.
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signaling in murine cells and for STAT 1 degradation,
respectively (Young et al., 2001; Chatziandreou et al., 2002;
Wansley and Parks, 2002). In addition, a faint band of
STAT2 could be detected in HeLa cells expressing S93/P,
S98/P, or S104/P by using ECL. These findings suggest that
the domain containing these amino acids plays an important
role in blocking STAT. HeLa/hPIV2V cells and HeLa/
S104/P are resistant to IFN-, while they are sensitive to
IFN-. On the contrary, HeLa/SV41V, HeLa/S216D, and
HeLaI217R cells are resistant to both IFNs. Intriguingly,
HeLa/A105E and HeLa/H108P cells were found to be sen-
sitive to IFN-. The molecular mechanism by which HeLa/
A105E and HeLa/H108P cells cannot acquire the resistance
to IFN- remains unclear.
The fact that complete defect of both STAT1 and 2 could
not be found in any HeLa cells expressing mutated V
protein may be consistent with such reports that both
STAT1 and STAT2 proteins are needed in the host cell to
create a degradation (Parisien et al., 2002). Intriguingly,
some chimeric/mutant V expressing cells, e.g., HeLa/P125/
S173/P, HeLa/A105I, and HeLa/H108P cells, showed lower
expression of both STAT1 and STAT2 than did the untrans-
fected HeLa cells. The molecular mechanism by which
lower expression of both STAT1 and STAT2 occurs in
these chimeric V protein-expressing HeLa cells remains to
be elucidated.
An intact Zn2 binding cysteine cluster within the car-
boxyl-terminal domain of the V protein vaguely resembles
a RING finger domain (Thomas et al., 1988; Ohgimoto et
al., 1990). The RING finger motif is defined as Cys-X2-
Cys-Xn-Cys-X-His-X2-Cys-X2-Cys-Xn-Cys-X2-Cys,
where X is an arbitrary amino acid residue (Saurin et al.,
1996). The RING finger motif was first discovered in a
putative transcription factor and was claimed to be a com-
mon motif for DNA binding factors. Until recently, the
diversity of RING finger proteins was puzzling (Saurin et
al., 1996), but now emerging evidence directs the role of the
RING finger motif to the ubiquitin-ligase (E3) activity
(Jackson et al., 2000; Freemont, 2000). Ubiquitination is
performed by sequential actions of three enzymes. Ubiq-
uitin is first activated by E1 through the formation of a
high-energy thioester bond, and is subsequently transferred
to E2 via thioester bond (Yamao, 1999). Finally, E2 trans-
fers ubiquitin to its substrate with the help of a ubiquitin
ligase, E3 (Yamao, 1999). Ubiquitination and subsequent
degradation by the proteasome with correct timing are es-
sential for many cellular processes. These E3 proteins bind
to both target proteins and the ubiquitin E2 conjugating
enzymes, thereby selecting and promoting ubiquitination.
Cellular expression of V proteins from SV5 and hPIV2
induced polyubiquitylation of STAT1 and STAT2 targets
(Ulane and Horvath, 2002). Intriguingly, SV5 V-induced
polyubiquitin modification of STAT1 and hPIV2 V-induced
polyubiquitin modification of STAT2 are consistent with
their targeting specificities (Ulane and Horvath, 2002). The
V protein has been found to have intrinsic E3 activity
(Ulane and Horvath, 2002). The E3 activity of RING finger
proteins is dependent on the RING finger domain, which
binds an E2 ubiquitin-conjugating enzyme (Yamao, 1999).
Serine216 and Isoleucine217 are within an intact Zn2 bind-
ing cysteine cluster within the carboxyl-terminal domain of
the V protein. One possibility is that selective lowering of
STAT is dependent on what kind of E2 ubiquitin-conjugat-
ing enzyme is associated with V specific cysteine-rich do-
main. Another possibility is that these amino acid residues
determine to which substrate (STAT1 or 2) E2 ubiquitin-
conjugating enzyme transfers ubiquitins. Since Ulane and
Horvath (2002) have suggested that the V-dependent com-
plex also contains E2 activity, another possibility is that
these amino acid residues may determine selective specific-
ity of the E2 activity.
The RING finger motif and its variants have been found
in more than 200 proteins from diverse eukaryotes (Free-
mont, 2000). The well-known protooncogene c-Cbl, in
which a centrally located RING finger domain has been
demonstrated to be essential for c-Cbl’s function as ubiq-
uitination-promoting or E3 factor, facilitates the multiubiq-
uitination of activated, tyrosine phosphorylated receptor ty-
rosine kinases, thereby downregulating an activated signal
transduction pathway (Zheng et al., 2000). Recently, it has
been demonstrated that c-Cbl exerts a negative regulatory
function on IFN signaling by controlling STAT1 protein
levels (Blesofsky et al., 2001). Intriguingly, c-Cbl decreases
STAT1 levels in a ligand-independent manner, and acts by
suppressing protein synthesis rather than by promoting pro-
tein degradation (Blesofsky et al., 2001). We previously
found that STAT2 was scarcely pulse-labeled in HeLa cells
expressing the hPIV2 V protein (Nishio et al., 2001), sug-
gesting that synthesis of STAT2 is suppressed, or STAT2 is
very rapidly degraded in the cells. STAT1 is also barely
pulse-labeled in HeLa cells expressing the SV41 V protein
(unpublished data). Four amino acid residues, Alanine105,
Histidine108, Serine216, and Isoleucine217, of the hPIV2 V
protein might take part in influencing the translational con-
trol of STAT2 protein.
In summary, the regions on the hPIV2 V protein neces-
sary for STAT 2 lowering are discontinuous, and four amino
acid residues, Alanine105, Histidine108, Serine216, and Iso-
leucine217, are at least indispensable for STAT 2 lowering.
A diagram mapping the critical mutations and domains is
shown (Fig. 6).
Materials and methods
Viruses
Human parainfluenza type 2 virus (hPIV2; Toshiba
strain) and simian virus 41 (SV41, Toshiba strain) were
used in this study.
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Cells
HeLa cells were grown in Eagle’s MEM supplemented
with 5% fetal calf serum.
Antibodies
Anti-V protein of hPIV2 mAb (85A), which is also
cross-reactive with SV41 V protein, was previously de-
scribed (Nishio et al., 1999). For Western blot assay, anti-
STAT1 (IgG1) and anti-STAT2 (IgG1) mAbs were pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). For flow-cytometric analysis, anti-STAT1 mAb
(IgG1) was bought from BD Transduction Laboratories
(Lexington, KY, USA). Anti-human parainfluenza type 4A
virus NP protein mAb (3B, IgG1) was used as a control
antibody.
Western blot assay
The cell extracts were prepared with lysis buffer (150
mM NaCl, 50 mM Tris-HCl, pH 7.5, 0.6% NP40) contain-
ing 4 mM phenylmethylsulfonyl fluoride. The samples were
analyzed by SDS (sodium dodecyl sulfate)-PAGE (13%).
Electrophoretic transfer from gels onto PVDF transfer
membranes was carried out as described previously (Nishio
et al., 2001). The membranes were blocked with 5% skim
milk in PBS, treated with each monoclonal antibody (mAb)
at room temperature for 1 h, washed three times with 0.05%
Tween 20 in PBS (PBS/T), and treated with biotinylated
secondary antibody for 30 min. After washing with PBS/T,
one part of the membranes was immersed in the methanol-
PBS (2:8) containing 4-chloro-1-naphthol (0.3%) and hy-
drogen peroxide (0.009%), and the other part was immersed
in ECL Western blotting detection regents (Amersham
Pharmacia Biotech, Tokyo, Japan).
Immunofluorescent staining
The cells were fixed with 3% paraformaldehyde for 15
min at room temperature and rinsed twice with PBS. The
cells were permeabilized with PBS/Tween 20 (0.05%) for
30 min and washed twice with PBS. They were then incu-
bated for 60 min with primary antibody and washed three
times with PBS. Next, they were incubated for 60 min with
FITC-labeled secondary antibody, and washed with PBS.
Immunofluorescent stained cells were analyzed using a flu-
orescent microscope.
Flow-cytometric analysis
About 5  105 cells were fixed with 3% paraformalde-
hyde for 15 min at room temperature and rinsed twice with
PBS. The cells were permeabilized with PBS/Triton (0.1%)
for 30 min and washed twice with PBS. Subsequently, they
were incubated with 100 l of first antibody for 60 min at
room temperature, and then 100 l of FITC-conjugated
secondary antibody for 60 min at room temperature. Im-
munofluorescent-stained cells were analyzed on a FACScan
(Becton Dickinson) using Consort 30 software (Becton
Dickinson).
IFN susceptibility
The monolayers of various cells were incubated with 10
or 100 units of human IFN- (hIFN-) or hIFN for 24 h,
and then the cells were infected with about 100 PFU of
Sindbis virus. On day 3 post infection, plaque numbers were
counted.
Creation of chimeric recombinant plasmids and site-
directed mutagenesis
To create chimeric V proteins and mutated V proteins,
chimeric or mutated V genes were amplified by two-step
PCR-based overlap primer extension (Ho et al., 1989) at the
appropriate recombination site between hPIV2 and SV41 V
genes using the primers. The ends of the primers contain
complementary sequences and were inserted into the
pME18Sneo plasmid vector including SR promoter and
Neor gene, using standard molecular biology techniques.
The chimeric structures were checked by nucleotide se-
quencing.
Fig. 6. A summary diagram mapping the critical mutations and domains of hPIV2 V protein.
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Establishment of the cell lines that constitutively express
virus-specific protein
A cDNA clone of the hPIV2 V, SV41 V, chimera V, or
mutated V gene was inserted into plasmid pcDL-SR296
between PstI and KpnI sites. The cDNA fragment was
inserted between the ClaI and SalI sites of the vector pkan2.
Plasmid pkan2 contains the G418 (Geneticin; GIBCO) re-
sistance gene. The promoter in pkan2 is identical to the SR
promoter (SV40  ATL promoters). HeLa or cells were
transfected with each plasmid with Lipofectin (GIBCO).
After incubation at 37°C for 8 h, MEM with 10% calf serum
was added. After 2 days of further incubation the culture
medium was changed to MEM containing 10% FCS, 1
mg/ml geneticin, and 0.2% agarose, and the cells were
cultured for 3 weeks. Six lines of each the cell, at least, were
analyzed for STAT expression.
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